Valuation: Abbott Laboratories

Market Cap 19TCr 17TCr 16TCr 14TCr 26TCr 17,93200Cr 27TCr 1,85400Cr 75TCr 9,46500Cr 71TCr 70TCr 29,99900Cr P/E 2026 *
36.2x
P/E 2027 * 26.3x
Enterprise Value 21TCr 19TCr 17TCr 16TCr 30TCr 20,16400Cr 31TCr 2,08500Cr 84TCr 10,64200Cr 80TCr 78TCr 33,73200Cr EV / Sales 2026 *
4.26x
EV / Sales 2027 * 3.91x
Free-Float
86.16%
Yield 2026 *
2.37%
Yield 2027 * 2.53%
1 day+0.80%
1 week+6.11%
Current month+3.01%
1 month+12.21%
3 months+2.13%
6 months+22.29%
Current year-12.68%
1 week 103
Extreme 102.995
110.62
1 month 97.2
Extreme 97.2
110.62
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

333 0.0000%
30/09/26 Free

Director

318 0.0000%
30/09/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+6.11%-11.66%+14.15% 19TCr
-0.41%+5.25%+9.62%+36.27% 12TCr
+1.22%+3.03%-13.29%+12.43% 12TCr
-1.42%+1.35%-41.88%+5.74% 9.48TCr
+0.79%+4.65%-0.13%+74.46% 6.5TCr
-0.22%+1.61%+11.77%-23.46% 5.4TCr
+0.06%+19.74%-7.04%+56.54% 5.29TCr
-1.45%-7.57%-2.88%+55.56% 5.23TCr
-0.96%+3.92%+1.49%-10.71% 3.52TCr
-2.11%+5.61%+37.30%-14.87% 3.09TCr
Average -0.37%+4.39%-1.67%+20.61% 8.14TCr
Weighted average by Cap. -0.03%+4.44%-6.48%+21.77%

Financials

2026 *2027 *
Net sales 5TCr 4.46TCr 4.1TCr 3.72TCr 6.99TCr 4,73300Cr 7.17TCr 49TCr 20TCr 2,49800Cr 19TCr 18TCr 7,91800Cr 5.35TCr 4.78TCr 4.39TCr 3.99TCr 7.49TCr 5,07100Cr 7.68TCr 52TCr 21TCr 2,67600Cr 20TCr 20TCr 8,48300Cr
Net income 564.32Cr 504.17Cr 463.11Cr 420.6Cr 789.84Cr 53TCr 809.69Cr 5.53TCr 2.22TCr 28TCr 2.12TCr 2.07TCr 89TCr 766.31Cr 684.62Cr 628.86Cr 571.14Cr 1.07TCr 73TCr 1.1TCr 7.51TCr 3.02TCr 38TCr 2.88TCr 2.81TCr 1,21400Cr
Net Debt 2.36TCr 2.1TCr 1.93TCr 1.76TCr 3.3TCr 2,23100Cr 3.38TCr 23TCr 9.28TCr 1,17800Cr 8.84TCr 8.65TCr 3,73300Cr 2.01TCr 1.8TCr 1.65TCr 1.5TCr 2.82TCr 1,90800Cr 2.89TCr 20TCr 7.94TCr 1,00700Cr 7.56TCr 7.4TCr 3,19100Cr
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
03/26/03 $109.40 -0.69% 73,03,187
02/26/02 $110.16 +3.73% 88,46,364
30/26/30 $106.20 +1.56% 84,40,806
29/26/29 $104.57 +1.88% 72,85,422
28/26/28 $102.64 -0.45% 54,79,929
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
109.40USD
Average target price
118.52USD
Spread / Average Target
+8.34%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories